Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.75 USD | +1.85% | 0.00% | +14.58% |
Valuation
Fiscal Period: November | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 20.63 | 34.14 | 30.94 | 42.28 | 36.1 | 27.05 |
Enterprise Value (EV) 1 | 8.086 | 18.16 | 16.44 | 30.47 | 35.48 | 32.5 |
P/E ratio | 14.3 x | 9.19 x | 21 x | 13.8 x | 13 x | 43.7 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 0.98 x | 1.34 x | 1.39 x | 1.55 x | 1.3 x | 0.88 x |
EV / Revenue | 0.39 x | 0.71 x | 0.74 x | 1.12 x | 1.28 x | 1.06 x |
EV / EBITDA | 4.96 x | 3.87 x | 8.21 x | 7.14 x | 12.8 x | 21.9 x |
EV / FCF | 13.2 x | 7.13 x | -10.7 x | -14 x | -2.64 x | -5.49 x |
FCF Yield | 7.6% | 14% | -9.33% | -7.13% | -37.9% | -18.2% |
Price to Book | 0.83 x | 1.21 x | 1.05 x | 1.31 x | 1.04 x | 0.77 x |
Nbr of stocks (in thousands) | 2,578 | 2,578 | 2,578 | 2,578 | 2,578 | 2,578 |
Reference price 2 | 8.000 | 13.24 | 12.00 | 16.40 | 14.00 | 10.49 |
Announcement Date | 2/5/19 | 2/12/20 | 2/11/21 | 2/9/22 | 2/10/23 | 2/7/24 |
Income Statement Evolution (Annual data)
Fiscal Period: November | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 20.97 | 25.45 | 22.27 | 27.29 | 27.78 | 30.64 |
EBITDA 1 | 1.63 | 4.696 | 2.002 | 4.27 | 2.781 | 1.481 |
EBIT 1 | 1.311 | 4.317 | 1.625 | 3.886 | 2.387 | 0.556 |
Operating Margin | 6.25% | 16.96% | 7.3% | 14.24% | 8.59% | 1.81% |
Earnings before Tax (EBT) 1 | 1.422 | 4.439 | 1.69 | 3.734 | 3.499 | 0.826 |
Net income 1 | 1.441 | 3.713 | 1.472 | 3.058 | 2.787 | 0.632 |
Net margin | 6.87% | 14.59% | 6.61% | 11.2% | 10.03% | 2.06% |
EPS 2 | 0.5589 | 1.440 | 0.5709 | 1.186 | 1.081 | 0.2400 |
Free Cash Flow 1 | 0.6144 | 2.548 | -1.534 | -2.173 | -13.43 | -5.914 |
FCF margin | 2.93% | 10.01% | -6.89% | -7.96% | -48.35% | -19.3% |
FCF Conversion (EBITDA) | 37.69% | 54.26% | - | - | - | - |
FCF Conversion (Net income) | 42.64% | 68.63% | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 2/5/19 | 2/12/20 | 2/11/21 | 2/9/22 | 2/10/23 | 2/7/24 |
Balance Sheet Analysis
Fiscal Period: November | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | - | 5.45 |
Net Cash position 1 | 12.5 | 16 | 14.5 | 11.8 | 0.62 | - |
Leverage (Debt/EBITDA) | - | - | - | - | - | 3.679 x |
Free Cash Flow 1 | 0.61 | 2.55 | -1.53 | -2.17 | -13.4 | -5.91 |
ROE (net income / shareholders' equity) | 5.97% | 14% | 5.1% | 9.91% | 8.31% | 1.8% |
ROA (Net income/ Total Assets) | 3.1% | 9.18% | 3.23% | 6.7% | 3.16% | 0.64% |
Assets 1 | 46.52 | 40.45 | 45.54 | 45.62 | 88.29 | 99.18 |
Book Value Per Share 2 | 9.600 | 11.00 | 11.40 | 12.50 | 13.50 | 13.70 |
Cash Flow per Share 2 | 4.070 | 5.390 | 5.670 | 5.920 | 5.960 | 3.990 |
Capex 1 | 0.29 | 0.25 | 0.69 | 6.31 | 13.2 | 2.56 |
Capex / Sales | 1.4% | 0.98% | 3.08% | 23.12% | 47.55% | 8.36% |
Announcement Date | 2/5/19 | 2/12/20 | 2/11/21 | 2/9/22 | 2/10/23 | 2/7/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+14.58% | 35.45M | |
+77.16% | 2,159B | |
+20.41% | 623B | |
+31.87% | 622B | |
+6.78% | 254B | |
+14.54% | 185B | |
+4.12% | 162B | |
-36.56% | 136B | |
+34.57% | 127B | |
+35.67% | 105B |
- Stock Market
- Equities
- MPAD Stock
- Financials Micropac Industries, Inc.